Analysis of Alzheimer’s brains revealed age-related accumulation of cancer driver mutations, particularly in microglia. These ...
The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current ...
The enzyme RNA polymerase (RNAP) carries out transcription, copying DNA into RNA. It's the first step in gene expression, and ...
We are pleased to nominate Lykke to our Board of Directors,” said James Shannon, MD, Chairperson of the Board of ProQR Therapeutics. “Her extensive experience in global drug development and broad ...
Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...
These discoveries suggest that certain cancer treatments may be useful therapeutically for Alzheimer’s disease.
Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today announced the ...
Is Alzheimer’s a form of "brain cancer" of the immune system? A new study links cancer-driving mutations in microglia to ...
Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results